Importer of Controlled Substances; Notice of Registration, 8775-8776 [2011-3409]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 31 / Tuesday, February 15, 2011 / Notices
collection: There are an estimated 1,556
total annual burden hours associated
with this collection.
If additional information is required
contact: Mrs. Lynn Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street, NE., Suite 2E–502,
Washington, DC 20530.
Dated: February 9, 2011.
Lynn Murray,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2011–3298 Filed 2–14–11; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0043]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested: Drug
Questionnaire, DEA Form 341
30-Day Notice of Information
Collection under Review.
jdjones on DSK8KYBLC1PROD with NOTICES
ACTION:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 75, Number 239, page
77906 on December 14, 2010, allowing
for a 60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until March 17, 2011. This
process is conducted in accordance with
5 CFR 1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Raymond A. Pagliarini,
Jr., Assistant Administrator, Human
Resources Division, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152.
Written comments concerning this
information collection should be sent to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attn: DOJ Desk Officer. The best
way to ensure your comments are
VerDate Mar<15>2010
15:51 Feb 14, 2011
Jkt 223001
received is to e-mail them to
oira_submission@omb.eop.gov or fax
them to 202–395–7285. All comments
should reference the 8 digit OMB
number for the collection or the title of
the collection. If you have questions
concerning the collection, please call
Raymond A. Pagliarini, Jr., Assistant
Administrator, Human Resources
Division, Drug Enforcement
Administration, 8701 Morrissette Drive,
Springfield, VA 22152 or the DOJ Desk
Officer at 202–395–3176.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of this Information
Collection 1117–0043:
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: Drug
Questionnaire (DEA Form 341).
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: DEA Form 341.
Component: Human Resources
Division, Drug Enforcement
Administration, U.S. Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals.
Other: None.
Abstract: DEA Policy states that a past
history of illegal drug use may be a
disqualification for employment with
DEA. This form asks job applicants
specific questions about their personal
history, if any, of illegal drug use.
(5) An estimate of the total number of
respondents and the amount of time
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
8775
estimated for an average respondent to
respond: It is estimated that 173,800
respondents will respond annually,
taking 5 minutes to complete each form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 14,483 annual burden hours.
If additional information is required
contact: Lynn Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, 145 N Street, NE., Suite
2E–502, Washington, DC 20530.
Dated: February 9, 2011.
Lynn Murray,
Department Clearance Officer, Department of
Justice.
[FR Doc. 2011–3319 Filed 2–14–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 1, 2010,
and published in the Federal Register
on November 12, 2010, 75 FR 69459,
Formulation Technologies LLC., 11501
Domain Drive, Suite 130, Austin, Texas
78758, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
Fentanyl (9801), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance for analytical
characterization, secondary packaging,
and for distribution to clinical trial sites.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Formulation Technologies LLC. to
import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Formulation Technologies LLC. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
E:\FR\FM\15FEN1.SGM
15FEN1
8776
Federal Register / Vol. 76, No. 31 / Tuesday, February 15, 2011 / Notices
the basic class of controlled substance
listed.
DEPARTMENT OF JUSTICE
Dated: February 4, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
[FR Doc. 2011–3409 Filed 2–14–11; 8:45 am]
BILLING CODE 4410–09–P
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 1, 2010,
and published in the Federal Register
on November 12, 2010, 75 FR 69459,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
jdjones on DSK8KYBLC1PROD with NOTICES
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Fenethylline (1503) ......................................................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ...............................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
Etorphine (except HCl)(9056) ......................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Pholcodine (9314) .......................................................................................................................................................................................
Dextromoramide (9613) ...............................................................................................................................................................................
Dipipanone (9622) .......................................................................................................................................................................................
Racemoramide (9645) .................................................................................................................................................................................
Trimeperidine (9646) ...................................................................................................................................................................................
Tilidine (9750) ..............................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Benzoylecgonine (9180) ..............................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Oripavine (9330) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Poppy Straw Concentrate (9670) ................................................................................................................................................................
Fentanyl (9801).
VerDate Mar<15>2010
15:51 Feb 14, 2011
Jkt 223001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
E:\FR\FM\15FEN1.SGM
15FEN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 76, Number 31 (Tuesday, February 15, 2011)]
[Notices]
[Pages 8775-8776]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3409]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 1, 2010, and published in the Federal
Register on November 12, 2010, 75 FR 69459, Formulation Technologies
LLC., 11501 Domain Drive, Suite 130, Austin, Texas 78758, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as an importer of Fentanyl (9801), a basic class of
controlled substance listed in schedule II.
The company plans to import the listed controlled substance for
analytical characterization, secondary packaging, and for distribution
to clinical trial sites.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Formulation Technologies LLC. to import the basic class
of controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Formulation
Technologies LLC. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of
[[Page 8776]]
the basic class of controlled substance listed.
Dated: February 4, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-3409 Filed 2-14-11; 8:45 am]
BILLING CODE 4410-09-P
